Evercore ISI Analyst: 160,000 Patients Affected by AbbVie Hepatitis Pact By: Benzinga via Benzinga December 23, 2014 at 16:13 PM EST AbbVie Inc's (NYSE: ABBV) agreement to be the exclusive hepatitis C treatment supplier to pharmacy benefits manager Express ... Read More >> Related Stocks: AbbVie Express Scripts Holding Gilead Sciences